Vibhavadi Medical Center PCLBKK:VIBHA +0.74%70 ROE % is 4.68% as of Mar. 2026, which is 56% below its 10-year median of 10.56. GuruFocus rates BKK:VIBHA with a GF Score™ of 70/100 and a GF Value™ of ฿1.67 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 623 Healthcare Providers & Services companies, Vibhavadi Medical Center PCL ranks better than 79.45% on this metric.
The historical rank and industry rank for Vibhavadi Medical Center PCL's ROE % or its related term are showing as below:
BKK:VIBHA'
s ROE % Range Over the Past 10 Years
Min: 5.75 Med: 10.56 Max: 17.74
Current: 16.84
During the past 13 years, Vibhavadi Medical Center PCL's highest ROE % was 17.74%. The lowest was 5.75%. And the median was 10.56%.
BKK:VIBHA's ROE % is ranked better than 79.45% of 623
companies
in the Healthcare Providers & Services industry
Industry Median: 5.88
vs BKK:VIBHA: 16.84
Vibhavadi Medical Center PCL (BKK:VIBHA) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Vibhavadi Medical Center PCL ROE % Related Terms
Vibhavadi Medical Center PCL ROE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Vibhavadi Medical Center PCL's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vibhavadi Medical Center PCL ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Vibhavadi Medical Center PCL's ROE % distribution charts can be found below:
* The bar in red indicates where Vibhavadi Medical Center PCL's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Vibhavadi Medical Center PCL (BKK:VIBHA) has a ROE % of 4.68% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Vibhavadi Medical Center PCL and its competitors. This is 56% below median its historical median of 10.56. Over the past decade, Vibhavadi Medical Center PCL's ROE % has ranged from 5.75 to 17.74. According to the industry distribution chart, Vibhavadi Medical Center PCL ranks #128 out of 623 companies in the Healthcare Providers & Services industry, placing it in the top 20.5%.
Is Vibhavadi Medical Center PCL's ROE % too high?
Vibhavadi Medical Center PCL's current ROE % of 4.68% is 56% below median its 10-year median of 10.56. Over the past 10 years, this metric has ranged from a low of 5.75 to a high of 17.74. The Healthcare Providers & Services industry median ROE % is 5.88. Vibhavadi Medical Center PCL's value of 4.68% is 20.4% below this industry median. Based on the distribution chart, Vibhavadi Medical Center PCL ranks #128 out of 623 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Vibhavadi Medical Center PCL has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vibhavadi Medical Center PCL's ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Vibhavadi Medical Center PCL ranks #128 out of 623 companies for ROE %. This places Vibhavadi Medical Center PCL in the top 21% of its industry — outperforming the majority of peers. The industry median ROE % is 5.88. Vibhavadi Medical Center PCL's value of 4.68% is 20.4% below this benchmark. Historically, Vibhavadi Medical Center PCL's own ROE % has ranged from 5.75 to 17.74 over the past decade. While the company's 10-year median is 10.56 vs. the industry median of 5.88, Vibhavadi Medical Center PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.88, based on 623 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vibhavadi Medical Center PCL's current ROE % of 4.68% is 20.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Vibhavadi Medical Center PCL and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vibhavadi Medical Center PCL's current ROE % is 4.68%, which is 56% below median its own 10-year median of 10.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vibhavadi Medical Center PCL stock overvalued right now?
Based on GuruFocus' analysis, Vibhavadi Medical Center PCL (BKK:VIBHA) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿1.67, compared to a current price of ฿1.37 — trading 18% below its estimated fair value. The current ROE % is 4.68%, which is 56% below median its 10-year median of 10.56 and 20.4% below the Healthcare Providers & Services industry median of 5.88. Vibhavadi Medical Center PCL's overall GF Score™ is 70/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Vibhavadi Medical Center PCL (BKK:VIBHA), the current ROE % is 4.68% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vibhavadi Medical Center PCL (BKK:VIBHA) Overvalued in 2026?
Based on GuruFocus' analysis, Vibhavadi Medical Center PCL stock appears to be undervalued.
The current stock price of ฿1.37 is trading 18% below its estimated GF Value™ of ฿1.67.
GuruFocus considers Vibhavadi Medical Center PCL to be Modestly Undervalued.
Key valuation signals for BKK:VIBHA:
ROE %: 4.68% (56% below median its 10-year median of 10.56)
GF Value™: ฿1.67 vs. price of ฿1.37 (18% below fair value)
Industry Position: 20.4% below the Healthcare Providers & Services median (#128 of 623)
No single metric tells the full story. See the BKK:VIBHA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vibhavadi Medical Center PCL provides the medical services known as Vibhavadi Hospital. The services provided include Pediatric Diseases, General Surgery, Orthopedic Center, General Medicine, Women's Health, Gastrointestinal Center, Cardiology, Neurology, Brain Tumor Surgery, Gamma Knife Radiosurgery for Brain, Cancer, Respiratory Diseases, Plastic Surgery, ENT (Ear, Nose, Throat) Department, Dental Center, Life Style Health Screening Center, Lasik Center, Eye, Hemodialysis Department, Dermatology Center, and Other Clinics and Services. Its segments include Hospital provides general hospital and hospital in social security; and Others provide rental services and rental space. The majority of the revenue is derived from the Hospital segment.
70GF Score
Get the complete analysis for BKK:VIBHA
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:VIBHA has been successfully added to your 
